GlassScriptPhysician profile
Jennifer Horne
NPI 1174191571
$4,069.48
in general payments reported to CMS, 2019-2025
36 companies · $2,075 in 2025
The $2,075 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.51 · 2022: $221 · 2023: $378 · 2024: $1,366 · 2025: $2,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,818.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $551.18 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $537.99 | 2023-2025 | |
| Bridgebio Pharma, INC. | $360.58 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $322.79 | 2023-2025 | Onpattro, Amvuttra |
| Astrazeneca Pharmaceuticals LP | $252.48 | 2023-2025 | Lokelma, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.73 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $168.24 | 2024-2025 | Wegovy, Ozempic |
| Actelion Pharmaceuticals US, INC. | $158.28 | 2024-2025 | Opsynvi, Opsumit |
| Amgen INC. | $145.00 | 2024-2025 | Repatha, Repatha |
| Abiomed | $130.15 | 2024-2025 | Impella |
| Endo Pharmaceuticals INC. | $120.01 | 2021-2023 | Aveed, Xiaflex |
| Janssen Pharmaceuticals, INC | $119.84 | 2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $111.90 | 2025 | |
| Edwards Lifesciences Corporation | $88.50 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $83.59 | 2024-2025 | Eliquis, Camzyos |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $75.12 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $67.26 | 2023-2025 | Verquvo, Keytruda, Lynparza |
| Coloplast Corp | $65.52 | 2022-2023 | Speedicath |
| Harmony Biosciences LLC | $58.33 | 2024-2025 | |
| Antares Pharma, INC. | $52.18 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $44.62 | 2024 | Arcalyst |
| Lilly USA, LLC | $40.54 | 2025 | Zepbound, Mounjaro |
| Altathera Pharmaceuticals LLC | $35.30 | 2025 | Sotalol Hydrochloride |
| Heartflow, INC. | $33.66 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $29.39 | 2023 | Arcalyst |
| Sumitomo Pharma America, INC. | $27.06 | 2023 | Orgovyx |
| Boston Scientific Corporation | $26.68 | 2024 | Patientcare Link |
| Lantheus Medical Imaging, INC. | $23.81 | 2023 | Definity |
| Astellas Pharma US INC | $23.43 | 2023 | Veozah |
| Axonics, INC. | $22.80 | 2023 | Axonics |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.48 | 2024 | Lifevest |
| Tactile Systems Technology INC | $20.36 | 2024 | Flexitouch Plus, Entre Plus |
| Glaxosmithkline, LLC. | $18.52 | 2025 | Nucala |
| Myovant Sciences INC. | $17.28 | 2022 | |
| Procept Biorobotics Corporation | $15.99 | 2023 | Aquabeam Robotic System |
| Tolmar, INC. | $15.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Horne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.